Announcements Trials
Browse Landscape

Status

Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 72INDUSTRY 20NETWORK 3INDIV 3

Study Type

Observational 3Interventional 1

Sponsor

Conditions

Myasthenia Gravis 3Pancreatic Neoplasms 2Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Lymphoma 1Lung Neoplasms 1Leiomyoma 1Inflammatory Bowel Diseases 1Hematologic Neoplasms 1Colorectal Neoplasms 1Cerebral Tumors 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Tacrolimus 2Pyridostigmine Bromide 2Prednisone 2Steroids 1Mycophenolic Acid 1Methylprednisolone 1Methotrexate 1Immunosuppressive Agents 1Immunoglobulins, Intravenous 1Cyclosporine 1Cyclophosphamide 1Azathioprine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDIV × Observational × Myasthenia Gravis × Clear all
NCT07079020 2025-07-22

Efgartigimod for Consolidation Therapy in gMG

Da, Yuwei, M.D.

Not yet recruiting
130 enrolled

Myasthenia Gravis

NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Unknown
2,000 enrolled

Myasthenia Gravis

NCT04768465 2021-02-24

Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis

Da, Yuwei, M.D.

Unknown
160 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡